Ozoralizumab

A4DAB216 | Immune-mediated / inflammatory disorders | Approved
TNF/TNFA;ALB
non-canonical / None
Ablynx Eddingpharm Pfizer Taisho Pharmaceutical
Approved
Whole mAb
ATN-103 ATN103 ATN 103 PF-5230896 PF5230896 PF 5230896 TS-152 TS152 TS 152
—
IMGT PubChem (160704161) PubChem (340590268) PubChem (347911269) PubChem (381126410) PubChem (472423473) PubChem (480403209) PubChem (481988072) PubChem (517689396) Thera-SAbDab YAbS
Avg A4D Score
-0.6573
Score Range
-0.66
Structures
1
Avg. A4D Score per Structure
pH at Min / Max Aggregation Propensity

Associated Structural Profiles Level 2

Structure ID Source PDB Seq. Identity Avg. A4D Score pH (Min Agg.) pH (Max Agg.) Score CDR Score non-CDR
A4DAB216_3sqo_H_L 3sqo 96% -0.6573 6.5 9.0 0.0915 -0.7462